RYAN STEPHEN J 4
4 · ALLERGAN INC · Filed Mar 6, 2013
Insider Transaction Report
Form 4
ALLERGAN INCAGN
RYAN STEPHEN J
Director
Transactions
- Exercise/Conversion
Common Stock
2013-03-05$60.60/sh+5,700$345,420→ 10,969.752 total - Sale
Common Stock
2013-03-05$110.00/sh−5,700$627,000→ 5,269.752 total - Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2013-03-05−5,700→ 0 totalExercise: $60.60Exp: 2017-05-01→ Common Stock (5,700 underlying)
Holdings
- 42,613(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2012.
- [F2]Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
- [F3]S & A Ryan Living 1994 Trust, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
- [F4]Option is fully vested and exercisable on the date of the next regular annual meeting of stockholders of Allergan, Inc. at which directors are to be elected following the date of grant.